MX337348B - Metodos para purificar virus utilizando cromatografia de permeacion en gel. - Google Patents

Metodos para purificar virus utilizando cromatografia de permeacion en gel.

Info

Publication number
MX337348B
MX337348B MX2013012627A MX2013012627A MX337348B MX 337348 B MX337348 B MX 337348B MX 2013012627 A MX2013012627 A MX 2013012627A MX 2013012627 A MX2013012627 A MX 2013012627A MX 337348 B MX337348 B MX 337348B
Authority
MX
Mexico
Prior art keywords
methods
gel permeation
permeation chromatography
purifying viruses
viruses
Prior art date
Application number
MX2013012627A
Other languages
English (en)
Other versions
MX2013012627A (es
Inventor
Matthew C Coffey
Allison Hagerman
Roxna Kapadia
Sarah Serl
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Publication of MX2013012627A publication Critical patent/MX2013012627A/es
Publication of MX337348B publication Critical patent/MX337348B/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02—Separating microorganisms from their culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12051—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

La presente invención se refiere a tampones de elusión y métodos para purificar virus utilizando la cromatografía de permeación en gel. Los métodos son útiles, por ejemplo, para incrementar la recuperación de un virus con una columna de cromatografía de permeación en gel. Los tampones que se usan en los métodos incluyen al menos un excipiente seleccionado de histidina o sacaros, un catión divalente, un detergente no iónico, y una solución salina amortiguada con fosfato.
MX2013012627A 2011-04-29 2012-04-27 Metodos para purificar virus utilizando cromatografia de permeacion en gel. MX337348B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161480561P 2011-04-29 2011-04-29
PCT/CA2012/000406 WO2012145837A1 (en) 2011-04-29 2012-04-27 Methods of purifying viruses using gel permeation chromatography

Publications (2)

Publication Number Publication Date
MX2013012627A MX2013012627A (es) 2014-05-13
MX337348B true MX337348B (es) 2016-02-29

Family

ID=47067091

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013012627A MX337348B (es) 2011-04-29 2012-04-27 Metodos para purificar virus utilizando cromatografia de permeacion en gel.

Country Status (15)

Country Link
US (1) US20120273424A1 (es)
EP (1) EP2702147B1 (es)
JP (1) JP6029651B2 (es)
KR (2) KR20140024406A (es)
CN (1) CN103492557B (es)
AU (1) AU2012248082B2 (es)
CA (1) CA2832367A1 (es)
DK (1) DK2702147T3 (es)
EA (1) EA201391605A1 (es)
ES (1) ES2822199T3 (es)
IL (1) IL228491A (es)
MX (1) MX337348B (es)
SG (1) SG194449A1 (es)
TW (1) TW201307561A (es)
WO (1) WO2012145837A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2646051A4 (en) * 2010-12-02 2014-05-28 Oncolytics Biotech Inc FORMULATIONS OF LIQUID VIRUSES
MX349294B (es) 2010-12-02 2017-07-21 Oncolytics Biotech Inc Formulaciones virales liofilizadas.
RS57864B1 (sr) * 2013-06-17 2018-12-31 De Staat Der Nederlanden Vert Door De Minister Van Vws Ministerie Van Volksgezondheid Welzijn En Spo Postupci za sprečavanje agregacije virusnih komponenti
US11999975B2 (en) 2018-07-04 2024-06-04 Probiogen Ag Method for purifying an enveloped virus
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法
CN114544815B (zh) * 2022-03-01 2023-10-27 中牧实业股份有限公司 一种山羊痘病毒的定量检测方法
CN116718524B (zh) * 2023-06-26 2025-11-07 西安交通大学 一种基于细胞膜色谱技术的病毒颗粒检测方法
HUP2400154A1 (hu) * 2024-02-29 2025-09-28 Pecsi Tudomanyegyetem Elúciós oldat és tisztítási eljárás

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
EP0410207B1 (en) * 1989-07-24 1997-01-22 Bayer Corporation Stabilization of highly purified proteins
ATE328068T1 (de) * 1994-05-16 2006-06-15 Merck & Co Inc Papillomavirus vakzine
IL137510A0 (en) * 1998-02-17 2001-07-24 Schering Corp Compositions comprising viruses and methods for concentrating virus preparations
IL157304A0 (en) 2001-03-16 2004-02-19 Oncolytics Biotech Inc Method of extracting virus from cell culture
DE60327069D1 (de) * 2002-04-30 2009-05-20 Oncolytics Biotech Inc Verbesserte reinigungsmethode für viren
US7901921B2 (en) 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
EP1878791A1 (en) * 2006-07-11 2008-01-16 Bia Separations D.O.O. Method for influenza virus purification
DK2055311T3 (en) * 2006-08-07 2017-07-24 The Chemo-Sero-Therapeutic Res Inst METHOD OF MANUFACTURING LIVING COPPER VACCINE
SG191602A1 (en) * 2007-03-12 2013-07-31 Oncolytics Biotech Inc Reoviruses having modified sequences
JP4932940B2 (ja) * 2007-11-12 2012-05-16 セラクローン サイエンシーズ， インコーポレイテッド インフルエンザの治療および診断のための組成物および方法
US8227577B2 (en) * 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
MX349294B (es) * 2010-12-02 2017-07-21 Oncolytics Biotech Inc Formulaciones virales liofilizadas.
EP2646051A4 (en) * 2010-12-02 2014-05-28 Oncolytics Biotech Inc FORMULATIONS OF LIQUID VIRUSES

Also Published As

Publication number Publication date
EP2702147A1 (en) 2014-03-05
IL228491A (en) 2017-05-29
JP6029651B2 (ja) 2016-11-24
JP2014516515A (ja) 2014-07-17
CA2832367A1 (en) 2012-11-01
KR20140024406A (ko) 2014-02-28
EP2702147A4 (en) 2014-11-05
CN103492557A (zh) 2014-01-01
EA201391605A1 (ru) 2014-02-28
AU2012248082B2 (en) 2015-08-20
AU2012248082A1 (en) 2013-05-09
ES2822199T3 (es) 2021-04-29
KR102151890B1 (ko) 2020-09-03
DK2702147T3 (da) 2020-09-28
US20120273424A1 (en) 2012-11-01
MX2013012627A (es) 2014-05-13
SG194449A1 (en) 2013-12-30
EP2702147B1 (en) 2020-07-15
IL228491A0 (en) 2013-12-31
TW201307561A (zh) 2013-02-16
KR20190026059A (ko) 2019-03-12
WO2012145837A1 (en) 2012-11-01
CN103492557B (zh) 2015-07-29

Similar Documents

Publication Publication Date Title
SG194449A1 (en) Methods of purifying viruses using gel permeation chromatography
MX392274B (es) Cartuchos utiles en limpieza de soluciones de dialisis.
WO2016054598A3 (en) Antibodies that bind ebola glycoprotein and uses thereof
WO2013078170A8 (en) Purification of anti-c-met antibodies
EP3971286A3 (en) Nipah virus envelope pseudotyped lentiviruses and methods of use
PH12013501683A1 (en) Yeast-based therapeutic for chronic hepatitis b infection
ECSP13013060A (es) Composiciones de nucleasa terapéuticas y métodos
MX378747B (es) Complejos de proteínas de citomegalovirus.
PH12014502406B1 (en) Anti-il-23p19 antibodies
MX2010004892A (es) Terapia de combinacion para tratar infecciones virales persistentes.
IN2014KN02831A (es)
SI3660032T1 (sl) Postopki zajemanja in čiščenja beljakovin, izraženih v nesesalskem sistemu
BR112016022214A2 (pt) rnase para uso no tratamento ou prevenção de infecções virais
WO2013028334A3 (en) Use of small molecules in methods for purification of biomolecules
MX2019006568A (es) Eliminacion de ligandos lixiviados de purificacion de afinidad.
TN2013000388A1 (en) Anticoagulant antidotes
EA201990593A1 (ru) Непрерывный способ для снижения гетерогенности терапевтического белка
MX2018003080A (es) Cartuchos utiles en soluciones de dialisis de limpieza.
EA201590778A1 (ru) ОЧИСТКА КОМБИНИРОВАННОЙ ГАЛАКТОЦЕРЕБРОЗИД-β-ГАЛАКТОЗИДАЗЫ ЧЕЛОВЕКА (rhGALC)
PE20170586A1 (es) Nuevo uso de n,n-bis-2-mercaptoetil isoftalamida
WO2014160098A3 (en) Bordetella specific human recombinant antibodies and uses thereof
BR112014023946A8 (pt) Um sistema de elemento de desgaste
WO2012164003A3 (de) Solareinrichtung mit reflektorvorrichtung und reflektorvorrichtung
IT1400210B1 (it) Metodo di controllo della sicurezza nei luoghi di lavoro e sistema per la sua attuazione
PH12014501285A1 (en) Liquid activation system

Legal Events

Date Code Title Description
FG Grant or registration